This paper is only available as a PDF. To read, Please Download here.
Chronic widespread pain (CWP) in people with HIV-1 (PWH) is associated with a high
rate of disability and low quality of life, with prevalence estimates ranging from
25%-85%. However, the specific mechanisms that contribute to CWP in HIV are not understood.
Previously we demonstrated that PWH with CWP have increased hemolysis, elevated plasma
levels of cell-free heme, and attenuated levels of the heme degrading enzyme, heme
oxygenase 1 (HO-1). We also found that high cell-free heme and low HO-1 were associated
with hypersensitivity in animals. In this study, we hypothesized that high heme and
low HO-1 activates mast cells leading to degranulation and release of pain mediators
like, histamine and bradykinin in HIV. PWH who self-report CWP were recruited from
the University of Alabama at Birmingham HIV clinic. Animal models used in the study
included, C57BL/6 mice subjected to hemolysis by intraperitoneal injection of phenylhydrazine
hydrochloride (PHZ), HO-1 knockout mice, and HIV-1 transgenic rats overexpressing
HIV-1 proteins. Cellular studies were performed in MC/9 mast cells. Human findings
show that PWH with CWP have elevated plasma levels of histamine and bradykinin. HIV-1
transgenic rats also have elevated plasma levels of histamine and bradykinin and are
hypersensitive as estimated by a decrease in withdrawal threshold to von Frey stimulation.
In addition, data in mice with elevated plasma levels of free-heme, or decreased expression
of HO-1, show significantly elevated levels of the pain mediators, histamine and bradykinin.
Cellular data shows that high heme or low HO-1 induces mast cell degranulation and
the release of histamine and bradykinin. Together, these data suggest that heme-dependent
mast cell degranulation and the release of pain mediators may be contributing CWP
in HIV. Future studies will focus on determining strategies to stabilize mast cell
membrane in HIV and reduce hypersensitivity. Grant Number: RO1DA049657 Grant Name:
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.